Stockreport

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024 [Yahoo! Finance]

Portage Biotech Inc.  (PRTG) 
PDF the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, tod [Read more]